Effectiveness and Safety of Modified Fully Oral Nine-Month Treatment Regimens for Rifampicin-Resistant Tuberculosis: Prospective Cohort Study
Oleksandr KorotychWorld Health Organization (WHO) - World Health Organization Regional Office for EuropeJay AcharKarolinska InstitutetElmira GurbanovaUniversity of TartuArax HovhannesyanWorld Health Organization (WHO) - World Health Organization Regional Office for EuropeNino LomtadzeNational Center for Tuberculosis and Lung DiseasesAna CiobanuWorld Health Organization (WHO) - World Health Organization Regional Office for EuropeAlena SkrahinaMinsk Republican Scientific and Practical Centre of Pulmonology and TuberculosisGunta DravnieceLīga KukšaRiga East University HospitalMichael RichNaira KhachatryanGovernment of the Republic of Armenia - Ministry of Health, Republic of ArmeniaMyroslava GermanovychWorld Health Organization (WHO) - World Health Organization Regional Office for EuropeAbdullat KadyrovMinistry of Health, KyrgyzstanIana TerleievaMinistry of Health of Ukraineİrada AkhundovaMalik AdenovNational Scientific Center of PhthisiopulmonologyMyahri DurdyevaTurkmen State Medical UniversityNana KiriaNational Center for Tuberculosis and Lung DiseasesNatalia YatskevichMinistry of Health of the Republic of UzbekistanRovshen JumayevRustam NurovSaulius DiktanasKlaipeda UniversityValentina VilcChiril Draganiuc Institute of PhthisiopneumologyGiovanni Battista MiglioriIstituti Clinici Scientifici Maugeri IRCCS - Servizio di Epidemiologia Clinica delle Malattie RespiratorieAndrei DaduWorld Health Organization (WHO) - World Health Organization Regional Office for EuropeAskar YedilbayevWorld Health Organization (WHO) - World Health Organization Regional Office for Europe
ABI
Annotatsiya
Annotatsiya mavjud emas.
Mavzular
Identifikatorlar
Iqtiboslar va manbalar
0 ta iqtibos0 ta foydalanilgan manba